Put Options

7 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$5.73 - $11.95 $97,983 - $204,345
-17,100 Reduced 17.08%
83,000 $991,000
Q2 2024

Aug 15, 2024

BUY
$3.96 - $6.93 $5,940 - $10,395
1,500 Added 1.52%
100,100 $575,000
Q1 2024

May 07, 2024

BUY
$4.33 - $5.75 $136,395 - $181,125
31,500 Added 46.94%
98,600 $512,000
Q4 2023

Feb 14, 2024

SELL
$2.89 - $5.34 $23,987 - $44,322
-8,300 Reduced 11.01%
67,100 $353,000
Q3 2023

Nov 14, 2023

BUY
$2.8 - $4.94 $159,880 - $282,074
57,100 Added 312.02%
75,400 $248,000
Q2 2023

Aug 11, 2023

BUY
$0.93 - $3.64 $3,069 - $12,012
3,300 Added 22.0%
18,300 $52,000
Q1 2023

May 16, 2023

BUY
$1.07 - $2.95 $16,050 - $44,250
15,000 New
15,000 $16,000

Others Institutions Holding BVS

About Bioventus Inc.


  • Ticker BVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 61,664,200
  • Market Cap $644M
  • Description
  • Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...
More about BVS
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.